- Home
- ARTW vs BCLI Comparison
ARTW vs BCLI Comparison
Compare ARTW & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- BCLI
- Stock Information
- Founded
- ARTW 1956
- BCLI 2000
- Country
- ARTW United States
- BCLI United States
- Employees
- ARTW N/A
- BCLI N/A
- Industry
- ARTW Industrial Machinery/Components
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARTW Industrials
- BCLI Health Care
- Exchange
- ARTW Nasdaq
- BCLI Nasdaq
- Market Cap
- ARTW 8.7M
- BCLI 9.9M
- IPO Year
- ARTW N/A
- BCLI N/A
- Fundamental
- Price
- ARTW $1.50
- BCLI $1.21
- Analyst Decision
- ARTW
- BCLI Strong Buy
- Analyst Count
- ARTW 0
- BCLI 1
- Target Price
- ARTW N/A
- BCLI $30.00
- AVG Volume (30 Days)
- ARTW 13.4K
- BCLI 36.0K
- Earning Date
- ARTW 04-11-2025
- BCLI 03-31-2025
- Dividend Yield
- ARTW N/A
- BCLI N/A
- EPS Growth
- ARTW 17.02
- BCLI N/A
- EPS
- ARTW 0.06
- BCLI N/A
- Revenue
- ARTW $24,499,371.00
- BCLI N/A
- Revenue This Year
- ARTW N/A
- BCLI $170.09
- Revenue Next Year
- ARTW N/A
- BCLI N/A
- P/E Ratio
- ARTW $26.13
- BCLI N/A
- Revenue Growth
- ARTW N/A
- BCLI N/A
- 52 Week Low
- ARTW $1.33
- BCLI $1.05
- 52 Week High
- ARTW $4.15
- BCLI $11.25
- Technical
- Relative Strength Index (RSI)
- ARTW 31.94
- BCLI 31.67
- Support Level
- ARTW $1.51
- BCLI $1.12
- Resistance Level
- ARTW $1.64
- BCLI $1.28
- Average True Range (ATR)
- ARTW 0.07
- BCLI 0.11
- MACD
- ARTW -0.02
- BCLI -0.01
- Stochastic Oscillator
- ARTW 0.00
- BCLI 18.75
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.